PATENT CLAIM ANALYSIS

Application Number: 15937475
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["548", "373100"]

Abstract:
There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.

Claim (Index 20):
A method for treating a disease or disorder, comprising administering a thrombin-inhibiting compound according to  claim 1 , wherein R 2  is substituted or unsubstituted heteroalkyl, to a subject in need thereof in an amount effective to treat said disease or disorder, wherein the disease or disorder is selected from the group consisting of a thrombotic disorder, a disease or disorder involving a blood clot thrombus, fibrosis, multiple sclerosis, neuropathic pain, coagulation cascade inflammation, and a type of cancer selected from the group consisting of small cell lung cancer, glioma, prostate cancer, and breast cancer.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.60526
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13630201', '14776612', '15605566', '15811220', '14776641']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.804301187023999
- 35 USC 102 Novelty (BERT): 0.5574086295825945
- Combined Prediction Score: 0.7796119312798585
- Mean Citation Score: 464.241458
- Max Citation Score: 486.57462
- Similarity Product: 306.847400470562

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test